The intermediate and non-classical monocyte populations, both expressing CD16 (CD16+ monocytes), have a significantly larger fraction of GFAP+ cells in 228 brain tumour patients than in healthy controls (P < 0.001) (Supplementary Fig. 3A). The gene discussed is GFAP; the disease is brain neoplasm.